Sandy Draper
Stock Analyst at Guggenheim
(2.92)
# 1,701
Out of 5,090 analysts
113
Total ratings
59.14%
Success rate
20.63%
Average return
Main Sectors:
Stocks Rated by Sandy Draper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Buy | $464 → $432 | $548.12 | -21.19% | 12 | Jul 24, 2024 | |
| EVH Evolent Health | Maintains: Hold | $34 → $28 | $3.94 | +610.66% | 10 | May 14, 2024 | |
| IQV IQVIA Holdings | Downgrades: Neutral | n/a | $225.85 | - | 8 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | n/a | $184.31 | - | 15 | Feb 15, 2024 | |
| GDRX GoodRx Holdings | Maintains: Buy | $8 → $10 | $2.71 | +269.00% | 4 | Aug 10, 2023 | |
| DOCS Doximity | Downgrades: Neutral | n/a | $45.93 | - | 3 | Aug 9, 2023 | |
| TOI The Oncology Institute | Maintains: Buy | $3 → $2 | $3.03 | -33.99% | 3 | Jun 16, 2023 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $271 → $263 | $185.80 | +41.55% | 13 | Apr 28, 2023 | |
| AGL agilon health | Maintains: Buy | $21 → $30 | $0.65 | +4,499.82% | 3 | Mar 6, 2023 | |
| HQY HealthEquity | Maintains: Buy | $89 → $94 | $94.51 | -0.54% | 11 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $7.59 | - | 10 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $51 | $23.84 | +113.93% | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $143 → $129 | $244.55 | -47.25% | 2 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $55 | $44.61 | +23.29% | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $226 → $168 | $101.06 | +66.24% | 2 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $12 | $39.20 | -69.39% | 1 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $9.56 | +423.01% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $11.90 | +446.22% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $2.60 | +1,284.62% | 4 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $167 | $242.00 | -30.99% | 3 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.36 | - | 2 | May 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $11.70 | +438.46% | 1 | Sep 20, 2016 |
Medpace Holdings
Jul 24, 2024
Maintains: Buy
Price Target: $464 → $432
Current: $548.12
Upside: -21.19%
Evolent Health
May 14, 2024
Maintains: Hold
Price Target: $34 → $28
Current: $3.94
Upside: +610.66%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $225.85
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $184.31
Upside: -
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $2.71
Upside: +269.00%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $45.93
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3 → $2
Current: $3.03
Upside: -33.99%
ICON Public Limited Company
Apr 28, 2023
Maintains: Buy
Price Target: $271 → $263
Current: $185.80
Upside: +41.55%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21 → $30
Current: $0.65
Upside: +4,499.82%
HealthEquity
Dec 7, 2022
Maintains: Buy
Price Target: $89 → $94
Current: $94.51
Upside: -0.54%
Oct 24, 2022
Upgrades: Neutral
Price Target: n/a
Current: $7.59
Upside: -
Aug 12, 2022
Maintains: Buy
Price Target: $36 → $51
Current: $23.84
Upside: +113.93%
May 25, 2021
Maintains: Buy
Price Target: $143 → $129
Current: $244.55
Upside: -47.25%
May 18, 2021
Maintains: Buy
Price Target: $84 → $55
Current: $44.61
Upside: +23.29%
May 12, 2021
Maintains: Buy
Price Target: $226 → $168
Current: $101.06
Upside: +66.24%
Apr 21, 2021
Initiates: Hold
Price Target: $12
Current: $39.20
Upside: -69.39%
Jan 28, 2021
Initiates: Buy
Price Target: $50
Current: $9.56
Upside: +423.01%
Jan 28, 2021
Initiates: Buy
Price Target: $65
Current: $11.90
Upside: +446.22%
May 13, 2020
Maintains: Buy
Price Target: $30 → $36
Current: $2.60
Upside: +1,284.62%
Mar 26, 2020
Maintains: Buy
Price Target: $175 → $167
Current: $242.00
Upside: -30.99%
May 31, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.36
Upside: -
Sep 20, 2016
Initiates: Buy
Price Target: $63
Current: $11.70
Upside: +438.46%